Moscow, Russia

Oleg Gennadievich Rodin

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 6.2

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2013-2017

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Oleg Gennadievich Rodin: Pioneering Cholesterol Treatments

Introduction: Oleg Gennadievich Rodin is a noted inventor based in Moscow, Russia, who has made significant contributions to the pharmaceutical field. With two patents to his name, Rodin is recognized for his innovative work in developing compounds and methods aimed at cholesterol mobilization.

Latest Patents: Rodin's latest patents focus on "Compounds, compositions and methods useful for cholesterol mobilization." These inventions highlight classes of pharmaceutically-active heterocyclic compounds, including their pharmaceutically acceptable salts and hydrates. They also encompass methods for treating or preventing diseases related to cholesterol, which involve administering a therapeutically or prophylactically effective amount of these described compounds. The emphasis on cholesterol mobilization reveals the importance of his research in addressing health concerns related to cholesterol levels and related disorders.

Career Highlights: Oleg Gennadievich Rodin is currently affiliated with Cerenis Therapeutics Holding S.A., a company dedicated to developing innovative therapies for cardiovascular and metabolic diseases. His work there demonstrates a strong commitment to advancing medical science and improving patient outcomes through innovative solutions.

Collaborations: Throughout his career, Rodin has collaborated with esteemed colleagues such as Daniela Carmen Oniciu and Jean-Louis Henri Dasseux. These partnerships have enabled him to enhance the quality and impact of his research, fostering a collaborative environment that promotes scientific discovery.

Conclusion: Oleg Gennadievich Rodin stands out as a significant figure in the realm of pharmaceutical innovations, particularly through his contributions aimed at cholesterol management. His patents represent crucial advances in the field, and his work with Cerenis Therapeutics Holding S.A. underscores his role as a pioneer in developing effective therapies for health improvement.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…